1628811-81-3Relevant articles and documents
Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD
De Savi, Chris,Cox, Rhona J.,Warner, Daniel J.,Cook, Anthony R.,Dickinson, Mark R.,McDonough, Amy,Morrill, Louis C.,Parker, Beth,Andrews, Glen,Young, Simon S.,Gilmour, Peter S.,Riley, Rob,Dearman, Matthew S.
, p. 4661 - 4676 (2014/07/07)
Oral phosphodiesterase 4 (PDE4) inhibitors, such as cilomilast and roflumilast, have been shown to be efficacious against chronic obstructive pulmonary disease (COPD). However, these drugs have been hampered by mechanism-related side effects such as nause